An Unbiased View of Oteseconazole
Kantarjian et al53 assessed the efficacy and security of dasatinib, as as opposed with imatinib, for the 1st-line procedure of CML-CP. 5 hundred and nineteen people with freshly diagnosed CML-CP ended up randomly assigned to acquire dasatinib in a dose of one hundred mg as soon as day by day (259 sufferers) or imatinib in a dose of four hundred mg